Table 2.
Sex | Age | Device | Procedure time (minutes) | Time to onset (days) | Pathogen | Risk factors |
---|---|---|---|---|---|---|
Male | 81 | CRT-D | 164 | 22 | Staphylococcus epidermidis | Haematoma, renal insuff., oral anticoagulation, neoplasia, heart insuff., long procedure, male gender, long procedure |
Male | 61 | ICD | 50 | 25 | Staphylococcus epidermidis | Haematoma, heart insuff., male gender, younger age |
Male | 81 | VVI-R | 47 | 12 | Staphylococcus aureus | Haematoma, early revision due to lead dislodgement, skin disorder, COPD, heart insuff., oral anticoagulation (Afib), Diabetes, male gender |
Male | 83 | VVI-R | 52 | 59 | Staphylococcus aureus | Chronic renal insufficiency, oral anticoagulation (Afib), heart insuff., diabetes, male gender |
Female | 83 | DDD-R | 31 | 7 | Staphylococcus epidermidis, ConS | Acute on chronic renal failure, malignancy, upgrade revision |
Female | 73 | CRT-D | 92 | 12 | Staphylococcus epidermidis | Chronic renal insuff., heart insuff. Diabetes, oral anticoagulation, long procedure |
All major CIED infections occurred in the H2O2 group.
Afib, atrial fibrillation; ConS; Coagulase-negative Staphylococci; COPD, chronic obstructive pulmonary disease; CRT-D, implantable cardioverter defibrillator able to deliver cardiac resynchronization therapy; DDD-R, dual-chamber rate modulated permanent pacemaker; ICD, implantable cardioverter defibrillator; insuff., insufficiency; VVI-R, single chamber (ventricular pacing) rate modulated permanent pacemaker.